Gout Therapeutics Market Size Projected To Be Valued At $9,815.6 Million By 2026: Polaris Market Research

April 16 08:58 2019
Gout Therapeutics Market Size Projected To Be Valued At $9,815.6 Million By 2026: Polaris Market Research

Polaris Market Research
The new published report by Polaris Market Research, the global gout therapeutics market is anticipated to reach USD 9,815.6 million by 2026 growing at a CAGR of 15.2% from 2018 to 2026.

The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report published by Polaris Market Research. The report “Gout Therapeutics Market Size, Share, Trends & Analysis Report, By Drug Class (Urate-Lowering Agents, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Colchicine); By Disease Condition (Chronic Gout, Acute Gout); By Region, Segment Forecast, 2019 – 2026” provides in depth analysis of the current and future market trends.

Request A Sample Report At:
https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market/request-for-sample

The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder. Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.

As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share. 

Gout Therapeutics Market (USD Billion) & Y-o-Y Growth(%)

Get Full Research Summary on Global Gout Therapeutics Market Analysis Available At:
https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market

NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.

Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market. 

Request for Discount Pricing With Your Specific Research Needs At:
https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market/request-for-discount-pricing

Polaris Market Research has segmented the global Gout Therapeutics Market on the basis of Drug Class, Disease Condition and region:

Gout Therapeutics by Drug Class Outlook (Revenue, USD Million, 2015 – 2026)

  • Topical Hemostats
  • Corticosteroids
  • Nonsteroidal Anti-inflammatory Drugs [NSAIDs]
  • Colchicine

Gout Therapeutics by Disease Condition Outlook (Revenue, USD Million, 2015 – 2026)

  • Chronic Gout
  • Acute Gout

Gout Therapeutics – Region Outlook (Revenue, USD Billion, 2015 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Belgium
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Israel
    • South Africa

 

Leading Key Players of Gout Therapeutics Market

  • AstraZeneca
  • Horizon Pharma plc
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline plc
  • Novartis AG
  • Merck & Co. Inc.
  • Teijin Pharma Limited e
  • Regeneron Pharmaceuticals, Inc.
  • Ironwood Pharmaceuticals, Inc.
  • JW Pharmaceutical
  • Selecta Biosciences, Inc.
  • Grunenthal Group

 

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers.

For More Information: https://www.polarismarketresearch.com

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Mr.Rohit
Email: Send Email
Phone: +1-646-568-9980
Address:30 Wall Street 8th Floor New York City, NY 10005 United States
City: New York
State: New York 10005
Country: United States
Website: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market

  Categories: